121 related articles for article (PubMed ID: 33373779)
1. Comparison of DCE-MRI of murine model cancers with a low dose and high dose of contrast agent.
Zhou X; Fan X; Mustafi D; Pineda F; Markiewicz E; Zamora M; Sheth D; Olopade OI; Oto A; Karczmar GS
Phys Med; 2021 Jan; 81():31-39. PubMed ID: 33373779
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
[TBL] [Abstract][Full Text] [Related]
3. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
4. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
5. Comparison of region-of-interest-averaged and pixel-averaged analysis of DCE-MRI data based on simulations and pre-clinical experiments.
He D; Zamora M; Oto A; Karczmar GS; Fan X
Phys Med Biol; 2017 Sep; 62(18):N445-N459. PubMed ID: 28786402
[TBL] [Abstract][Full Text] [Related]
6. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
[TBL] [Abstract][Full Text] [Related]
7. R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T.
Kim J; Moestue SA; Bathen TF; Kim E
Tomography; 2019 Sep; 5(3):308-319. PubMed ID: 31572792
[TBL] [Abstract][Full Text] [Related]
8. Effect of T2* correction on contrast kinetic model analysis using a reference tissue arterial input function at 7 T.
Zhang J; Freed M; Winters K; Kim SG
MAGMA; 2015 Dec; 28(6):555-63. PubMed ID: 26239630
[TBL] [Abstract][Full Text] [Related]
9. The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains.
Woodall RT; Barnes SL; Hormuth DA; Sorace AG; Quarles CC; Yankeelov TE
Magn Reson Med; 2018 Jul; 80(1):330-340. PubMed ID: 29115690
[TBL] [Abstract][Full Text] [Related]
10. Five-dimensional quantitative low-dose Multitasking dynamic contrast- enhanced MRI: Preliminary study on breast cancer.
Wang N; Xie Y; Fan Z; Ma S; Saouaf R; Guo Y; Shiao SL; Christodoulou AG; Li D
Magn Reson Med; 2021 Jun; 85(6):3096-3111. PubMed ID: 33427334
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
Hompland T; Ellingsen C; Rofstad EK
BMC Cancer; 2012 Nov; 12():544. PubMed ID: 23173554
[TBL] [Abstract][Full Text] [Related]
13. Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard tofts model in the diagnosis of prostate cancer.
Zhou X; Fan X; Chatterjee A; Yousuf A; Antic T; Oto A; Karczmar GS
Phys Eng Sci Med; 2023 Sep; 46(3):1215-1226. PubMed ID: 37432557
[TBL] [Abstract][Full Text] [Related]
14. Signal intensity form of the Tofts model for quantitative analysis of prostate dynamic contrast enhanced MRI data.
Fan X; Chatterjee A; Medved M; Oto A; Karczmar GS
Phys Med Biol; 2021 Jan; 66(2):025002. PubMed ID: 33181487
[TBL] [Abstract][Full Text] [Related]
15. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer.
Fan X; Chatterjee A; Pittman JM; Yousuf A; Antic T; Karczmar GS; Oto A
Acad Radiol; 2022 Jun; 29(6):796-803. PubMed ID: 34583866
[TBL] [Abstract][Full Text] [Related]
18. Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment.
Longo DL; DastrĂ¹ W; Consolino L; Espak M; Arigoni M; Cavallo F; Aime S
Magn Reson Imaging; 2015 Jul; 33(6):725-36. PubMed ID: 25839393
[TBL] [Abstract][Full Text] [Related]
19. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
[TBL] [Abstract][Full Text] [Related]
20. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
Delrue LJ; Casneuf V; Van Damme N; Blanckaert P; Peeters M; Ceelen WP; Duyck PC
MAGMA; 2011 Aug; 24(4):225-32. PubMed ID: 21567161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]